Adjunctive Cannabidiol Therapy in Schizophrenia

New research looks at the effects of CBD on positive and negative psychotic symptoms, cognitive performance, level of functioning, and the treating psychiatrist’s overall clinical impression.

Related Videos
Related Content

From the Pages of Psychiatric Times: May 2023

May 27th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Poster Highlights Racial/Ethnic Disparities in LAI Use

May 22nd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Exploring the Future of Mental Health

May 19th 2023

The Week in Review: May 8-12

May 13th 2023

From the Pages of Psychiatric Times: May 2023

May 27th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Poster Highlights Racial/Ethnic Disparities in LAI Use

May 22nd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Exploring the Future of Mental Health

May 19th 2023

The Week in Review: May 8-12

May 13th 2023

From the Pages of Psychiatric Times: May 2023

May 27th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Poster Highlights Racial/Ethnic Disparities in LAI Use

May 22nd 2023

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

May 11th 2021

Exploring the Future of Mental Health

May 19th 2023

The Week in Review: May 8-12

May 13th 2023
© 2023 MJH Life Sciences

All rights reserved.